NPB-1575
NPB-1575 is a potent, orally active and brain-penetrant anti-inflammatory agent. NPB-1575 mitigates neuroinflammation and resists ferroptosis by activating the IRS2/Nrf2/NF-κB axis. NPB-1575 shows protective effect against cerebral ischemic injury and improves the neurological functional prognosis. NPB-1575 can be used for the study of ischemic stroke[1].
Product Specifications
CAS Number
161984-54-9
UNSPSC
12352005
Target
Ferroptosis; FOXO; Keap1-Nrf2; NF-κB; NO Synthase; Quinone Reductase
Related Pathways
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Smiles
OC1=CC(O)=C(C/C=C(C)/C)C(CCC2=CC(O)=C(O)C=C2)=C1
Molecular Formula
C19H22O4
Molecular Weight
314.38
References & Citations
[1]Li XN, et al. NPB-1575 attenuates neuroinflammation and resists ferroptosis in rat ischemic stroke via IRS2 signaling pathway. Acta Pharmacol Sin. 2025 Jun 5.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15112965 1 Vial
Lentiviral mouse Stk26 shRNA (UAS) - Lentiviral mouse Stk26 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details